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Abstract
The study of primary cilia is of broad interest both in terms of disease
pathogenesis and the fundamental biological role of these structures. Murine
models of ciliopathies provide valuable tools for the study of these diseases.
However, it is important to consider the precise phenotype of murine models
and how dependant it is upon genetic background. Here we compare and
contrast murine models of , a frequent genetic cause of JoubertCep290
syndrome in order to refine our concept of genotype-phenotype correlations.
 Simon Ramsbottom ( )Corresponding author: Simon.Ramsbottom@ncl.ac.uk
 Ramsbottom S, Miles C and Sayer J. How to cite this article: Murine  phenotypes are modified by genetic backgrounds andCep290
  2015, :590 (doi: provide an impetus for investigating disease modifier alleles [version 1; referees: 2 approved] F1000Research 4
)10.12688/f1000research.6959.1
 © 2015 Ramsbottom S . This is an open access article distributed under the terms of the ,Copyright: et al Creative Commons Attribution Licence
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Work was funded by the Medical Research Council (MR/M012212/1), support to all authors.Grant information:
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 Competing interests: No competing interests were disclosed.
 20 Aug 2015, :590 (doi: ) First published: 4 10.12688/f1000research.6959.1







 20 Aug 2015, :590 (doi: )First published: 4 10.12688/f1000research.6959.1
 20 Aug 2015, :590 (doi: )Latest published: 4 10.12688/f1000research.6959.1
v1
Page 1 of 5
F1000Research 2015, 4:590 Last updated: 22 SEP 2015
Background
The role of cilia and the diseases associated with aberrant cilial for-
mation and function, termed ciliopathies, have in the last ten years 
become a major area of study1. Within the field of human genetics, 
the understanding of the importance of these organelles has given 
rise to a profound shift in the way that the study and treatment of a 
range of diseases is undertaken. Many syndromes, although known 
to be pleiotropic in their manifestation, were previously considered 
to be discrete entities requiring specific individualised treatment. 
The discovery that many of these syndromes appear to have a large 
degree of commonality in their disease mechanism via the malfor-
mation or mis-localisation of cilia, has lead to the thinking that they 
may indeed exist within a spectrum, and subsequently that they 
may respond to similar treatments.
Joubert syndrome (JBTS) is an autosomal recessive ciliopathy 
which gives rise to cerebellar vermis aplasia, hypotonia, ataxia 
and developmental delay. It is often associated with retinal degen-
eration, leading to blindness. It may also be associated with a 
cystic renal phenotype known as nephronophthisis (NPHP). The 
most common genetic lesion among patients with JBTS who 
present with the cerebello-oculo-renal phenotype is CEP290 
(OMIM 610142)2. Mutations in the CEP290 gene are associated 
with numerous disorders including Leber congenital amaurosis3, 
Senior-Loken syndrome, JBTS4,5 and Meckel syndrome6. There 
have been over 100 different mutation sites reported in human 
patients7. Work attempting to understand genotype-phenotype cor-
relations of CEP290 mutations based on total amount of protein has 
recently been reported8. A lack of correlation between genotype and 
phenotype may also be dependent on oligogenic inheritance and 
a mutational load in ciliary genes9. While this diversity has been 
suggested to contribute to these differential outcomes, recent work 
utilising mouse models of JBTS has indicated that there may be 
underlying mechanisms that modify the disease phenotype, even 
when the exact Cep290 mutation site is conserved.
In early 2015, Rachel et al. described a Cep290KO mouse model 
of JBTS, which exhibits retinal degeneration and hydrocephalus in 
juvenile mice, with a slowly progressive renal pathology resulting 
in cysts in adult mice10. While the retinal degeneration and cere-
bral phenotypes broadly reflect those observed in JBTS patients, 
the murine kidney phenotype is unusual, as in humans it typically 
presents in teenage years and young adults as opposed to being of 
late onset. This lack of a significant renal aspect in the pathology 
may simply reflect the diversity in the JBTS phenotype. It should be 
noted however that while a renal phenotype in JBTS is not univer-
sal, patients with mutations in CEP290, as opposed to other JBTS 
genes, do more commonly have renal disease (nephronophthisis)11.
Rachel et al. report that a significant number (80%) of Cep290KO 
mice do not survive past weaning, suggesting that the reported phe-
notype is that of less affected individuals. Additionally, to obtain 
viable mice, the authors propagated the mutation within a mixed 
background of C57BL/6 and 129/SvJ; mice could not be bred purely 
on either line past the N3 generation. While this genetic diversity 
in the population may echo that of a human scenario, it can be dif-
ficult to interpret data with the lack of experimental control that this 
diversity introduces. Furthermore it is likely that to fully ascertain 
an accurate picture of the disease model, it is necessary to use a 
significantly greater number of animals, which is not desirable. To 
investigate a wider phenotypic spectrum of Cep290-related disor-
ders, Rachel et al. also use a gene trap (gt) model of Cep290, in 
which the pGT0xfT2 gene trap vector is inserted in intron 25, result-
ing in the introduction of a premature stop codon10. This lesion is 
similar to that of a number of common mutation sites within human 
CEP290, and so potentially provides a good model of the human 
disease. Cep290gt were backcrossed onto 129SvJ and Rachel 
et al. reported a significant level of lethality, as was reported for 
the Cep290KO model, with the vast majority of Cep290gt mice dying 
in utero between E12 and E14. Surviving mice displayed massively 
dilated kidneys, with loss of tubules and the formation of large cysts, 
a phenotype more similar to that of infantile nephronophthisis. As 
with the Cep290KO model however, the large mortality rate within 
the population needs to be considered, as those mice that do survive 
may not be fully representative.
This gene trap model (Cep290gt) is similar to a murine model 
reported in 2014, described as Cep290LacZ12. In this study, a simi-
larly high level of in utero mortality was reported when Cep290LacZ 
mice were backcrossed on to a C57BL/6 background. On the 
129/Ola background however mice were fertile and viable beyond 
12 months12. Although the two studies generated mice from the 
same embryonic gene trap cell line (CC0582 [SIGTR, http://
www.sanger.ac.uk/resources/mouse/sigtr/]), differences in the 
phenotype can be observed. While the retinal degeneration and 
ventriculomegaly were broadly similar between the two stud-
ies, kidneys of Cep290LacZ mice were not massively dilated as 
described by Rachel et al., but had progressive formation of cysts 
reminiscent of human nephronophthisis12. Cysts were observed 
in newborn mice, and became progressively larger over the first 
4 weeks, instead of developing after 12 months. This disparity in 
the viability and phenotype of mice containing the same genetic 
alteration indicates that there are significant genetic modifiers 
specific to each strain of mice which can adversely affect the 
way in which this disease presents. The genetic diversity present 
between human populations therefore may provide some answers 
as to the broad range of phenotypes seen in JBTS patients. In 
the case of mutations such as those in Cep290 which do have 
pleiotropic effects, the difference between the outcomes in differ-
ent mouse strains provides an opportunity to study how genetic 
variability affects the disease phenotype. By utilising strains with 
known discrete polymorphisms it should be possible to identify 
variants that correlate with specific outcomes, allowing for a 
much greater understanding of the role that specific genetic modi-
fiers play in human disease and allowing therapies to be directed 
at these genetic modifiers.
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In recent years, it has become increasingly more evident that many ciliopathies exist not as separate
diseases, but instead fall along a spectrum.  mutations may cause the severeMeckel syndrome 1 (MKS1)
Meckel Gruber syndrome, but recently, has been reported by Romani  (2014) to also be responsibleet al.
for cases of the relatively more mild Joubert syndrome (JBTS). Our research on the centrosome and
 gene supports the notion that mutations within the same genespindle pole associated protein 1 (CSPP1)
can carry a wide range of phenotypes (Tuz , 2015).  We identified 18 individuals with JBTS from 14et al.
families with biallelic truncating mutations in , and saw no evidence of a correlation betweenCSPP1
phenotype and the site of truncation. Surprisingly, individuals with the most N-terminal truncations
displayed the least severe phenotype. Our findings also revealed that siblings with the same mutations
had varying phenotypes, suggesting that other factors outside the mutation of the ciliopathy gene itself
plays a role in the ultimate phenotype of the affected individual.
The phenotypic heterogeneity of individuals with JBTS with the same mutations has not gone unnoticed.
Recently, Ben-Omran . (2015) described two Qatari families with histories of consanguineous et al
marriages with the same  mutation, but yet, the probands displayed clinical heterogeneity.CSPP1
Ben-Omran and colleagues (2015) argue that highly inbred families likely have less diversity in genetic
modifiers, and attribute their findings of clinical heterogeneity to unidentified stochastic events that occur
in development. They correctly acknowledge that a disadvantage of their study is the lack of identical
twins.
Murine ciliopathy models provide one way of controlling for the contribution of genetic background to the
eventual phenotype of the affected individual. In this correspondence from Ramsbottom, Miles, and
Sayer, the authors provide important insight into the role of genetic background in modifying transgenic
ciliopathy phenotypes. Here, the authors reflect on a recent publication in the journal Human Molecular
Genetics by Rachel (2015) which describes different ciliopathy phenotypes in mice with different et al. 
mutations (a constitutive deletion of Cep290 (proposed null) and a genetrap allele (proposedCep290 
truncated Cep290)). Moreover, the phenotypes were clearly modified by the genetic background of the
mice. Further support for this came from comparisons of these phenotypes to other published Cep290 
transgenic mice with different genetic alterations. Genetic background and the modifiers that can be in
these backgrounds is a significant consideration that needs to be appreciated in the cilia field as it has in
many other fields, such as behavioral neuroscience. In fact, we have published work in which we have
shown that C57BL/6J mice with a targeted deletion of , another gene causing Joubert syndrome, dieAhi1
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within 12 hours after birth, but if these mice are backcrossed to FVB, Balbc/J, or Swiss Webster mice (>10
generations), then post-natal survivability is significantly enhanced and most mice can reach adulthood.
This correspondence serves as a very important reminder that the genetic background on which you are
studying your ciliopathy phenotype can result in different phenotypes dependent on the mouse strain and
therefore needs to be considered in interpreting one's results. Consequently, identification of such
differing ciliopathy phenotypes on different genetic backgrounds also serve as an important tool for not
only potentially identifying modifiers of ciliopathy phenotypes, but may also result in the identification of
new ciliopathy genes.
Ramsbottom, Miles, and Sayer argue that a difference in genetic background could account for disparities
in some phenotypes amongst individuals with the same mutation, a finding that is supported by our work
in humans and mice. However, as the authors point out, murine models of ciliopathies do not always
recapitulate the findings in affected individuals with JBTS. Thus, a possible difference between murine
and human regulation of ciliopathy phenotype must also be considered.
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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In this correspondence Ramsbottom and colleagues refer to a publication by Rachel (2015) in whichet al. 
phenotypes in mice strains with mutations in Cep290 (knock-out and a gen trap model) were studied, and
a comparison with patients with Joubert syndrome (JBTS) with CEP290 mutations is made. In brief: mice
develop a retinal degeneration, hydrocephalus, and a rather late onset progressive renal pathology, while
JBTS patients develop kidney disease in childhood or early adulthood. In addition the majority of
knock-out mice do not survive past weaning, thus the survivors are probably not really representative of
the phenotype, Ramsbottom argue that differences between the outcomes in different mouse strainset al 
provide an opportunity to study how genetic variability affects the disease phenotype. This point is well
taken. Looking at affected children (in my professional activity) even within the same sibship, with
identical mutations, there is often marked intrafamilial variability of the phenotype, pointing to the
relevance of genetic modifiers and probable interaction with other cilia-genes. Studies of mouse strains
(and zebra fish) have greatly contributed to understanding Joubert related genes, however the animal
phenotype may differ from humans - as illustrated by the lack of hydrocephalus in CEP290 mutated JBTS
patients.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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